Skip to content

Evaluation the effects of L Carnitine on quality of life of the cirrhotic patients

Evaluation the effects of L Carnitine on quality of life of the cirrhotic patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180313039075N1
Enrollment
120
Registered
2021-01-03
Start date
2020-12-21
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis. Cirrhosis of the liver

Interventions

Intervention 1: Intervention group 1: 1000 mg L Carnitine by Zist Takhmir company will use daily for 24 weeks. Intervention 2: Intervention group 2: 2000 mg L Carnitine by Zist Takhmir company will

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Cirrhotic patients who referred to Liver clinic of Taleghani hospital with age 18-70 years old Cirrhotic patients who referred to Liver clinic of Taleghani hospital with known case of cirrhosis Cirrhotic patients who referred to Liver clinic of Taleghani hospital with Child score A or B Cirrhotic patients who referred to Liver clinic of Taleghani hospital with no administration of L-Carnitine before

Exclusion criteria

Exclusion criteria: Not tolerate use of L-Carnitine because of the gastrointestinal problem Gastrointestinal bleeding Uncontrolled malignant tumors Need of hemodialysis Pregnancy Receiving drugs causing hyperammonemia Overt hepatic encephalopathy Patients who do not accept to continue the study Patients with other significant background diseases (heart failure, chronic kidney disease,…)

Design outcomes

Primary

MeasureTime frame
Quality of life. Timepoint: First, 3 months later, 6 months later. Method of measurement: Standard questionnaire for quality life in cirrhotic patients.;Sarcopenia. Timepoint: First, 3 months later, 6 months later. Method of measurement: Evaluate gripe strength by dynamometer and muscle mass by bioelectrical impedance analysis (BIA).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Pasharavesh

Shahid Beheshti University of Medical Sciences

l.pasharavesh@gmail.com+98 21 2243 2521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026